Реперфузійне пошкодження міокарда

М.Т. Ватутін, Н.В. Калінкіна, Є.В. Єщенко, І.М. Кравченко 

Література

1. Бобров В.А. Реперфузионные аритмии: механизмы возникновения, клиническая значимость, методы коррекции // Здоровье Украины.– 2003.– № 73.
2. Ватутин Н.Т., Калинкина Н.В., Колесников В.С. Влияние фармакологического прекондиционирования на течение стенокардии напряжения // Материалы XIX Российского национального конгресса «Человек и лекарство».– М., 2012.– С. 54.
3. Ватутин Н.Т., Калинкина Н.В., Кравченко И.Н. Влияние триметазидина на течение инфаркта миокарда // Материалы конференции «Актуальные проблемы клинической кардиологии».– Донецк, 2012.– С. 18–19.
4. Лопатин Ю.М., Дронова Е.П. Клинико-фармакоэкономические аспекты применения триметазидина модифицированного высвобождения у больных ишемической болезнью сердца, подвергнутых коронарному шунтированию // Кардиология.– 2009.– № 2.– C. 15–21.
5. Маслов Л.Н., Лишманов Ю.Б., Колар Ф. и др. Гипоксическое прекондиционирование – феномен, обеспечивающий повышение толерантности кардиомиоцитов к гипоксии/реоксигенации // Рос. физиол. журн. им. И.М. Сеченова.– 2010.– Т. 96, № 12.– С. 1170–1189.
6. Мойбенко А.А., Досенко В.Е., Пархоменко А.Н. Эндогенные механизмы кардиопротекции как основа патогенетической терапии заболеваний сердца.– К.: Наукова думка, 2008.– 520 с.
7. Пархоменко А.Н. Феномен невосстановленного кровотока у больных с острым коронарным синдромом и возможные пути улучшения тканевой перфузии // Укр. кардіол. журн.– 2007.– № 5.– С. 17–25.
8. Ali Z.A., Callaghan C.J., Lim E. et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial // Circulation.– 2007.– Vol. 116.– P. 98–105.
9. Andreka G., Vertesaljai M., Szantho G. et al. Remote ischemic postconditioning protects the heart during acute myocardial infarction in pigs // Heart.– 2007.– Vol. 93(6).– P. 749–752.
10. Argaud L., Gomez L., Gateau-Roesch O. et al. Trimetazidine inhibits mitochondrial permeability transition pore opening and prevents lethal ischemia-reperfusion injury // J. Mol. Cell. Cardiol.– 2005.– Vol. 39 (6).– P. 893–899.
11. Banach M., Rysz J., Goch A. et al. The role of trimetazidine after acute myocardial infarction // Curr. Vasc. Pharmacol.– 2008.– Vol. 6 (4).– P. 282–291.
12. Bonello L., Sbragia P., Amabile N. et al. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention // Heart.– 2007.– Vol. 93 (6).– P. 703–707.
13. Bøtker H.E., Kharbanda R., Schmidt M.R. et al. Remote ischemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial // Lancet.– 2010.– Vol. 375 (9716).– P. 727–734.
14. Braunwald E., Kloner R.A. Myocardial reperfusion: a double-edged sword? // J. Clin. Invest.– 1985.– Vol. 76 (5).– P. 1713–1719.
15. Camici P.G., Prasad S.K., Rimoldi O.E. Stunning, hibernation, and assessment of myocardial viability // Circulation.– 2008.– Vol. 117 (1).– P. 103–114.
16. Darling C.E., Solari P.B., Smith C.S. et al. 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection // Basic. Res. Cardiol.– 2007.– Vol. 102 (3).– P. 274–278.
17. Díaz R., Paolasso E.A., Piegas L.S. et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group // Circulation.– 1998.– Vol. 98 (21).– P. 2227–2234.
18. Dixon S.R., Rizik D.G., Griffin J.J. et al. The COOL-MI Investigators. A prospective, randomized trial of mild hypothermia during primary percutaneous intervention for acute myocardial infarction (COOL-MI): one-year clinical outcome // J. Amer. Coll. Cardiol.– 2004.– Vol. 43 (Suppl. 1).– P. A251.
19. Downey J.M., Krieg T., Cohen M.V. Mapping preconditioning's signaling pathways: an engineering approach // Ann. N.Y. Acad. Sci.– 2008.– Vol. 1123.– P. 187–196.
20. Fan X., Schulz R. Matrix metalloproteinase-2: an emerging biomarker for reperfusion injury following percutaneous coronary intervention // Heart.– 2012.– Vol. 98 (1).– P. 1–2.
21. Francischetti I., Moreno J.B., Scholz M., Yoshida W.B. Leukocytes and the inflammatory response in ischemia-reperfusion injury // Rev. Bras. Cir. Cardiovasc.– 2010.– Vol. 25 (4).– P. 575–584.
22. Granfeldt A., Lefer D.J., Vinten-Johansen J. Protective ischemia in patients: preconditioning and postconditioning // Cardiovasc. Res.– 2009.– Vol. 83 (2).– P. 234–246.
23. Hausenloy D.J., Mwamure P.K., Venugopal V. et al. Effect of remote ischemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial // Lancet.– 2007.– Vol. 370.– P. 575–579.
24. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion // Am. J. Physiol. Heart Circ. Physiol.– 2005.– Vol. 288 (2).– P. H971–976.
25. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway // Cardiovasc. Res.– 2004.– Vol. 61 (3).– P. 448–460.
26. Hausenloy D.J., Yellon D.M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection // Heart Fail. Rev.– 2007.– Vol. 12 (3–4).– P. 217–234.
27. Inserte J., Barrabés J.A., Hernando V., Garcia-Dorado D. Orphan targets for reperfusion injury // Cardiovasc. Res.– 2009.– Vol. 83 (2).– P. 169–178.
28. Iskesen I., Kurdal A.T., Eserdag M. et al. Trimetazidine may protect the myocardium during cardiac surgery // Heart Surg. Forum.– 2009.– Vol. 12 (3).– P. E175–179.
29. Jennings R.B., Sommers H.M., Smyth G.A. et al. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog // Arch. Pathol.– 1960.– Vol. 70.– P. 68–78.
30. Jonassen A.K, Aasum E., Riemersma R.A. et al. Glucose-insulin-potassium reduces infarct size when administered during reperfusion // Cardiovasc. Drugs Ther.– 2000.– Vol. 14 (6).– P. 615–623.
31. Jonassen A.K., Sack M.N., Mjøs O.D., Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling // Circ. Res.– 2001.– Vol. 89 (12).– P. 1191–1198.
32. Kara A.F., Demiryürek S., Celik A. et al. Effects of trimetazidine on myocardial preconditioning in anesthetized rats // Eur. J. Pharmacol.– 2004.– Vol. 503 (1–3).– P. 135–145.
33. Kerendi F., Kin H., Halkos M.E. et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors // Basic. Res. Cardiol.– 2005.– Vol. 100 (5).– P. 404–412.
34. Kharbanda R.K., Mortensen U.M., White P.A. et al. Transient limb ischemia induces remote ischemic preconditioning in vivo // Circulation.– 2002.– Vol. 106.– P. 2881–2883.
35. Kloner R.A., Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1 // Circulation.– 2001.– Vol. 104 (24).– P. 2981–2989.
36. Kloner R.A., Nesto R.W. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection // Circulation.– 2008.– Vol. 117.– P. 2523–2533.
37. Kremastinos D.Th. The phenomenon of preconditioning today // Hell. J. Cardiol.– 2005.– Vol. 46.– P. 1–4.
38. Mamas M.A., Neyses L., Fath-Ordoubadi F. A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction // Exp. Clin. Cardiol.– 2010.– Vol. 15 (2).– P. e20–24.
39. Martins G.F., Siqueira Filho A.G., Santos J.B. et al. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting // Arq. Bras. Cardiol.– 2011.– Vol. 97 (3).– P. 209–216.
40. Masaya Kato, Keigo Dote, Shota Sasaki et al. Intracoronary Verapamil Rapidly Terminates Reperfusion Tachyarrhythmias in Acute Myocardial Infarction // Chest.– 2004.– Vol. 126.– P. 702–708.
41. Mewton N., Croisille P., Gahide G. et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction // J. Am. Coll. Cardiol.– 2010.– Vol. 55 (12).– P. 1200–1205.
42. Moore G.W., Hutchins G.M. Coronary artery bypass grafts in 109 autopsied patients. Statistical analysis of graft and anastomosis patency and regional myocardial injury // JAMA.– 1981.– Vol. 246 (16).– P. 1785–1789.
43. Murphy E., Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury // Physiol. Rev.– 2008.– Vol. 88 (2).– P. 581–609.
44. Niccoli G., Kharbanda R.K., Crea F., Banning A.P. No-reflow: again prevention is better than treatment // Eur. Heart J.– 2010.– Vol. 31 (20).– P. 2449–2455.
45. Opie L.H. Preconditioning and metabolic anti-ischemic agents // Eur. Heart J.– 2003.– Vol. 24 (20).– P. 1854–1856.
46. Perrelli M.G., Pagliaro P., Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species // World J. Cardiol.– 2011.– Vol. 3 (6).– P. 186–200.
47. Piana R., Paik S., Moscucci M. Incidence and Treatment of no-reflow after percutaneous coronary intervention // Circulation.– 1994.– Vol. 89.– P. 2514–2520.
48. Pinto D.S., Gibson C.M., Wykrzykowska J.J. Ischemic reperfusion injury of the heart // UpToDate Inc.– 2009.– http://www.uptodate.com/contents/ischemic-reperfusion-injury-of-the-heart.
49. Piot C., Croisille P., Staat P. et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction // New Engl. J. Med.– 2008.– Vol. 359 (5).– P. 473–481.
50. Pomblum V.J., Korbmacher B., Cleveland S. et al. Cardiac stunning in the clinic: the full picture // Interact. Cardiovasc. Thorac. Surg.– 2010.– Vol. 10 (1).– P. 86–91.
51. Ruiz-Meana M., García-Dorado D. Pathophysiology of ischemia-reperfusion injury: new therapeutic options for acute myocardial infarction // Rev. Esp. Cardiol.– 2009.– Vol. 62 (2).– P. 199–209.
52. Ruiz-Meana M., Rodríguez-Sinovas A., Cabestrero A. et al. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischemia-reperfusion injury // Cardiovasc. Res.– 2008.– Vol. 77 (2).– P. 325–333.
53. Schmidt M.R., Smerup M., Konstantinov I.E. et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning // Am. J. Physiol. Heart Circ. Physiol.– 2007.– Vol. 292 (4).– P. H1883–1890.
54. Staat P., Rioufol G., Piot C. et al. Postconditioning the human heart // Circulation.– 2005.– Vol. 112 (14).– P. 2143–2148.
55. Thibault H., Piot C., Staat P. et al. Long-term benefit of postconditioning // Circulation.– 2008.– Vol. 117 (8).– P. 1037–1044.
56. Van de Werf F., Bax J., Betriu A. et al. ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology // Eur. Heart J.– 2008.– Vol. 29 (23).– P. 2909–2945.
57. Venetucci L.A., Trafford A.W., O'Neill S.C., Eisner D.A. The sarcoplasmic reticulum and arrhythmogenic calcium release // Cardiovasc. Res.– 2008.– Vol. 77 (2).– P. 285–292.
58. Vinten-Johansen J., Shi W. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions // J. Cardiovasc. Pharmacol. Ther.– 2011.– Vol. 16 (3–4).– P. 260–266.
59. Weman S.M., Karhunen P.J., Penttilä A. et al. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting // Ann. Thorac. Surg.– 2000.– Vol. 70 (3).– P. 807–812.
60. Yang X.C., Liu Y., Wang L.F. et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention // J. Invasive Cardiol.– 2007.– Vol. 19 (10).– 424–430.
61. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury // New Engl. J. Med.– 2007.– Vol. 357 (11).– P. 1121–1135.
62. Zhang L., Zhang L., Li Y.H. et al. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction // Eur. J. Clin. Invest.– 2005.– Vol. 35 (3).– P. 164–170.
63. Zuidema M.Y., Zhang C. Ischemia/reperfusion injury: The role of immune cells // World J. Cardiol.– 2010.– Vol. 2 (10).– P. 325–332.